Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Fine

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Infection and Immunity|January 1, 1986
Activation of the alternative complement pathway by Sporothrix schenckiiE N Scott, H G Muchmore, D P Fine
Infection and Immunity|March 1, 1978
Evidence for quantitative variability of bacterial opsonic requirementsJ C Guckian, W D Christensen, D P Fine
The Journal of the Oklahoma State Medical Association|October 1, 1996
Overwhelming sepsis with Vibrio vulnificus: a coastal pathogen in OklahomaL D Rotz, D P Buckley, D P Fine
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytesJ C Guckian, W D Christensen, D P Fine
The American Journal of Pathology|May 1, 1973
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparationD P Fine, R D Buchanan, D G Colley
The Journal of Infectious Diseases|August 1, 1980
The role of opsonins in recovery from experimental pneumococcal pneumoniaJ C Guckian, G D Christensen, D P Fine
Clinical Immunology and Immunopathology|September 1, 1983
Meningococcal meningitis in a women with inherited deficiency of the ninth component of complementD P Fine, H Gewurz, M Griffiss, et al.
Immunology|January 1, 1981
Trypan blue inhibition of complement receptor function on various cellsB L Harper, D P Fine, J C Guckian, et al.
Medicine|January 1, 1990
Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986J L Kirk, D P Fine, D J Sexton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytesJ C Guckian, G D Christensen, J E Schweinle, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Infection and Immunity|January 1, 1986
Activation of the alternative complement pathway by Sporothrix schenckiiE N Scott, H G Muchmore, D P Fine
Infection and Immunity|March 1, 1978
Evidence for quantitative variability of bacterial opsonic requirementsJ C Guckian, W D Christensen, D P Fine
The Journal of the Oklahoma State Medical Association|October 1, 1996
Overwhelming sepsis with Vibrio vulnificus: a coastal pathogen in OklahomaL D Rotz, D P Buckley, D P Fine
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytesJ C Guckian, W D Christensen, D P Fine
The American Journal of Pathology|May 1, 1973
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparationD P Fine, R D Buchanan, D G Colley
The Journal of Infectious Diseases|August 1, 1980
The role of opsonins in recovery from experimental pneumococcal pneumoniaJ C Guckian, G D Christensen, D P Fine
Clinical Immunology and Immunopathology|September 1, 1983
Meningococcal meningitis in a women with inherited deficiency of the ninth component of complementD P Fine, H Gewurz, M Griffiss, et al.
Immunology|January 1, 1981
Trypan blue inhibition of complement receptor function on various cellsB L Harper, D P Fine, J C Guckian, et al.
Medicine|January 1, 1990
Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986J L Kirk, D P Fine, D J Sexton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Opsonization of pneumococci. I. Heat-labile serum activity other than complement is required for killing by human polymorphonuclear leukocytesJ C Guckian, G D Christensen, J E Schweinle, et al.
Pageof 4